Table 6 Sub-group analysis of clinical characteristics
That | Normal pathology | BilIN | p-value |
|---|---|---|---|
(n = 314) | (n = 15) | ||
Sex | 0.342 | ||
Male | 69 (22.0%) | 5 (33.3%) | |
Female | 245 (78.0%) | 10 (66.7%) | |
Age at operation (months) | 24.0 (4.2–54.0) | 17.0 (6.0–47.0) | 0.708 |
APBDU | 0.680 | ||
No | 38 (12.3%) | 1 (6.7%) | |
Yes | 182 (58.7%) | 11 (73.3%) | |
Unknown | 90 (29.0%) | 3 (20.0%) | |
Preoperative lab findings | |||
AST (IU/L) | 34.0 [28.0;50.0] | 38.0 [31.5;46.0] | 0.465 |
ALT (IU/L) | 20.0 [12.0;54.0] | 17.0 [10.5;33.0] | 0.550 |
T.bil (mg/dL) | 0.6 [ 0.4; 2.5] | 0.8 [ 0.5; 4.8] | 0.285 |
D.bil (mg/dL) | 0.3 [ 0.1; 0.8] | 0.5 [ 0.3; 1.0] | 0.149 |
Amylase (U/L) | 66.0 [32.0;112.0] | 121.5 [45.0;154.0] | 0.108 |
Lipase (U/L) | 36.5 [20.0;90.5] | 110.0 [47.0;693.0] | 0.034 |
Leukocytosis | 0.580 | ||
No | 229 (73.4%) | 10 (66.7%) | |
Yes | 83 (26.6%) | 5 (33.3%) | |